» Articles » PMID: 23443243

Insulin Signalling Mechanisms for Triacylglycerol Storage

Overview
Journal Diabetologia
Specialty Endocrinology
Date 2013 Feb 28
PMID 23443243
Citations 101
Authors
Affiliations
Soon will be listed here.
Abstract

Insulin signalling is uniquely required for storing energy as fat in humans. While de novo synthesis of fatty acids and triacylglycerol occurs mostly in liver, adipose tissue is the primary site for triacylglycerol storage. Insulin signalling mechanisms in adipose tissue that stimulate hydrolysis of circulating triacylglycerol, uptake of the released fatty acids and their conversion to triacylglycerol are poorly understood. New findings include (1) activation of DNA-dependent protein kinase to stimulate upstream stimulatory factor (USF)1/USF2 heterodimers, enhancing the lipogenic transcription factor sterol regulatory element binding protein 1c (SREBP1c); (2) stimulation of fatty acid synthase through AMP kinase modulation; (3) mobilisation of lipid droplet proteins to promote retention of triacylglycerol; and (4) upregulation of a novel carbohydrate response element binding protein β isoform that potently stimulates transcription of lipogenic enzymes. Additionally, insulin signalling through mammalian target of rapamycin to activate transcription and processing of SREBP1c described in liver may apply to adipose tissue. Paradoxically, insulin resistance in obesity and type 2 diabetes is associated with increased triacylglycerol synthesis in liver, while it is decreased in adipose tissue. This and other mysteries about insulin signalling and insulin resistance in adipose tissue make this topic especially fertile for future research.

Citing Articles

Integrated in vitro, in silico, and in vivo approaches to elucidate the antidiabetic mechanisms of Cicer arietinum and Hordeum vulgare extract and secondary metabolites.

Shahzad A, Liu W, Hussain S, Ni Y, Cui K, Sun Y Sci Rep. 2025; 15(1):6620.

PMID: 39994296 PMC: 11850774. DOI: 10.1038/s41598-025-89642-5.


Human miR-1 Stimulates Metabolic and Thermogenic-Related Genes in Adipocytes.

Diez-Sainz E, Milagro F, Aranaz P, Riezu-Boj J, Batrow P, Contu L Int J Mol Sci. 2025; 26(1.

PMID: 39796132 PMC: 11720367. DOI: 10.3390/ijms26010276.


Systemic and local lipid adaptations underlie regeneration in Drosophila melanogaster and Ambystoma mexicanum.

Kubler I, Kretzschmar J, Arredondo-Lasso M, Keeley S, Rossler L, Ganss K NPJ Regen Med. 2024; 9(1):33.

PMID: 39472660 PMC: 11522293. DOI: 10.1038/s41536-024-00375-x.


Rate of body weight gain during early gestation in F0 beef heifers has effects that extend multigenerationally to the F2 fetuses.

Baumgaertner F, Ramirez-Zamudio G, Menezes A, Jurgens I, Hirchert M, Hurlbert J J Anim Sci. 2024; 102.

PMID: 39324625 PMC: 11503215. DOI: 10.1093/jas/skae295.


Triiodothyronine (T3) promotes browning of white adipose through inhibition of the PI3K/AKT signalling pathway.

Huang L, Guo Z, Huang M, Zeng X, Huang H Sci Rep. 2024; 14(1):20370.

PMID: 39223267 PMC: 11369215. DOI: 10.1038/s41598-024-71591-0.


References
1.
Zhang B, Berger J, Hu E, Szalkowski D, Spiegelman B, Moller D . Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha. Mol Endocrinol. 1996; 10(11):1457-66. DOI: 10.1210/mend.10.11.8923470. View

2.
Perrier S, Darakhshan F, Hajduch E . IL-1 receptor antagonist in metabolic diseases: Dr Jekyll or Mr Hyde?. FEBS Lett. 2006; 580(27):6289-94. DOI: 10.1016/j.febslet.2006.10.061. View

3.
Zuniga L, Shen W, Joyce-Shaikh B, Pyatnova E, Richards A, Thom C . IL-17 regulates adipogenesis, glucose homeostasis, and obesity. J Immunol. 2010; 185(11):6947-59. PMC: 3001125. DOI: 10.4049/jimmunol.1001269. View

4.
Tabas I, Tall A, Accili D . The impact of macrophage insulin resistance on advanced atherosclerotic plaque progression. Circ Res. 2010; 106(1):58-67. PMC: 2805467. DOI: 10.1161/CIRCRESAHA.109.208488. View

5.
Dentin R, Tomas-Cobos L, Foufelle F, Leopold J, Girard J, Postic C . Glucose 6-phosphate, rather than xylulose 5-phosphate, is required for the activation of ChREBP in response to glucose in the liver. J Hepatol. 2011; 56(1):199-209. DOI: 10.1016/j.jhep.2011.07.019. View